Last reviewed · How we verify
NCT03877900: VIRTOPSY+
A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital
trial in Stillbirth and Fetal Death in 26 participants. Completed in 6 March 2020.
6 March 2020
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Besancon |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 26 |
| Start date | 28 February 2019 |
| Primary completion | 6 March 2020 |
| Estimated completion | 6 March 2020 |
| Sites | 1 location across France |
Conditions studied
- Stillbirth and Fetal Death — all drugs for Stillbirth and Fetal Death →
- Termination of Pregnancy — all drugs for Termination of Pregnancy →
- Neonatal Death — all drugs for Neonatal Death →
Sponsor
Centre Hospitalier Universitaire de Besancon
Who can join
Under 1 Month, any sex, with Stillbirth and Fetal Death or Termination of Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this project is to assess the feasibility of a new local post mortem procedure at Besançon University Hospital : Virtopsy+, magnetic resonance (MR) imaging with tissue sampling of the fetus and newborns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03877900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stillbirth and Fetal Death
Currently open trials in the same condition.
- NCT06005272 — Mothers Working to Prevent Early Stillbirth Study 20-28 · recruiting
- NCT05651347 — Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction · Phase 3 · recruiting
Other Centre Hospitalier Universitaire de Besancon trials
Trials by the same sponsor.
- NCT07492199 — High Depth Exome Sequencing on DNA From a Salivary Sample by Mouth Smear. · not yet recruiting
- NCT07438015 — VEXUS-REA : Evaluation of Ultrasound Parameters of Venous Congestion in Patients in a Medical Intensive Care Unit · NA · not yet recruiting
- NCT06796114 — Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du · NA · recruiting
- NCT06864065 — Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder · NA · recruiting
- NCT07067762 — Botulinum Toxin Injections Into the Salivary Glands of Cerebrospinal Children With Chronic Sialorrhea · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03877900 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Besancon
- Last refreshed: 5 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03877900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing